It has been reported that GLP-1 alleviates diabetic kidney disease by significantly decreasing urinary albumin and ameliorating renal pathological changes in vivo, and improves autophagy through mTOR signaling pathway (Yang et al., 2020). This evidence concerns the gene MTOR and diabetic kidney disease.